Expression of Thy 1.2 surface antigen increases significantly during the murine mesenchymal stem cells cultivation period

被引:19
作者
Eslaminejad, Mohamadreza Baghaban
Nadri, Samad
Hosseini, Reza Hajji
机构
[1] Royan Inst, Stem Cell Dept, Tehran, Iran
[2] Payam Noor Univ, Dept Biochem, Tehran, Iran
关键词
differentiation; Thy 1.2 surface antigen; murine mesenchymal stem cell;
D O I
10.1111/j.1440-169x.2007.00932.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
This study sought to investigate the absence or expression of some surface antigens on murine mesenchymal stem cells (mMSCs) during the cultivation period of primary culture to passage 3 (equivalent to about 15 or 16 population doubling number). For this purpose, bone marrow cells from 6-8-week-old mice (either NMRI or Balb/c) were cultivated in 75-cm(2) culture flask for three successive passages, in each of which the culture was examined for the expression of CD135, CD44, CD31, Thy1.2, CD11b, CD45, CD34, Vcam1, Sca-1, and c-Kit antigens, using flow cytometry. Passage-3 cells from each strain can easily be differentiated into bone and fat, which was indicative of their mesenchymal nature. Our results demonstrated that for each given antigen, the percentages of the cells expressing that antigen had been changed by subcultures. The statistical analysis showed that nearly all differences between the passages were statistically significant. In this term, the expressional changes of Thy 1.2 seemed to be very significant in such a way that the expression increased to about half of the whole population in passage 3. In conclusion, it seems that this antigen could be considered as an enriching antigen for mMSCs population from bone marrow adherent cell culture.
引用
收藏
页码:351 / 364
页数:14
相关论文
共 46 条
[1]   Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection [J].
Baddoo, M ;
Hill, K ;
Wilkinson, R ;
Gaupp, D ;
Hughes, C ;
Kopen, GC ;
Phinney, DG .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2003, 89 (06) :1235-1249
[2]  
BALDWIN HS, 1994, DEVELOPMENT, V120, P2539
[3]  
BERESFORD JN, 1989, CLIN ORTHOP RELAT R, P270
[4]   Bone marrow stromal stem cells: Nature, biology, and potential applications [J].
Bianco, P ;
Riminucci, M ;
Gronthos, S ;
Robey, PG .
STEM CELLS, 2001, 19 (03) :180-192
[5]   Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome [J].
Chapel, A ;
Bertho, JM ;
Bensidhoum, M ;
Fouillard, L ;
Young, RG ;
Frick, J ;
Demarquay, C ;
Cuvelier, F ;
Mathieu, E ;
Trompier, F ;
Dudoignon, N ;
Germain, C ;
Mazurier, C ;
Aigueperse, J ;
Borneman, J ;
Gorin, NC ;
Gourmelon, P ;
Thierry, D .
JOURNAL OF GENE MEDICINE, 2003, 5 (12) :1028-1038
[6]  
Conget PA, 1999, J CELL PHYSIOL, V181, P67, DOI 10.1002/(SICI)1097-4652(199910)181:1<67::AID-JCP7>3.0.CO
[7]  
2-C
[8]   Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion [J].
Devine, SM ;
Bartholomew, AM ;
Mahmud, N ;
Nelson, M ;
Patil, S ;
Hardy, W ;
Sturgeon, C ;
Hewett, T ;
Chung, T ;
Stock, W ;
Sher, D ;
Weissman, S ;
Ferrer, K ;
Mosca, J ;
Deans, R ;
Moseley, A ;
Hoffman, R .
EXPERIMENTAL HEMATOLOGY, 2001, 29 (02) :244-255
[9]  
Dexter T M, 1984, Kroc Found Ser, V18, P57
[10]   Murine mesenchymal stem cells isolated by low density primary culture system [J].
Eslaminejad, Mohamadreza Baghaban ;
Nikmahzar, Aghbibi ;
Taghiyar, Leila ;
Nadri, Samad ;
Massumi, Mohamad .
DEVELOPMENT GROWTH & DIFFERENTIATION, 2006, 48 (06) :361-370